Mealey's (January 8, 2020, 9:30 AM EST) -- BOSTON — Eight former employees of Aegerion Pharmaceuticals Inc. have agreed to pay $6.5 million to settle a whistleblower lawsuit alleging that they caused the filing of false claims by marketing a cholesterol drug for off-label use, according to a stipulation of settlement filed Dec. 19 in federal court in Massachusetts (United States, ex rel. Michele Clark, et al. v. Aegerion Pharmaceuticals, Inc., et al., No. 13-11785, D. Mass.)....